Samir Rashmikant Patel - 02 Mar 2026 SCHEDULE 13D/A Report for Akari Therapeutics Plc Ordinary Shares, $0.000000005 par value (AKTX)

Filing Manager: Samir Rashmikant Patel
Reporting Manager: Samir R. Patel
Security: Akari Therapeutics Plc Ordinary Shares, $0.000000005 par value
Symbol: AKTX
Shares outstanding: 93,511,682,692 shares
Disclosed Ownership: 9,725,215,000 shares
Ownership: 10%
Form type: SCHEDULE 13D/A
Filing time: 04 Mar 2026, 16:44:49 UTC
Date of event: 02 Mar 2026
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
Samir R. Patel	10%	9,725,215,000	9,725,215,000	0	/s/ Samir R. Patel	Samir R. Patel, Authorized Signatory	0001702447